首页|BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition

扫码查看
原文链接
  • 万方数据
  • 维普

MelanomaBromodomain and extra terminal domain(BET)inhibitorFerroptosisCell deathAKR1C2Immunotherapy

Yu Meng、Hui-Yan Sun、Yi He、Qian Zhou、Yi-Huang Liu、Hui Su、Ming-Zhu Yin、Fu-Rong Zeng、Xiang Chen、Guang-Tong Deng

展开 >

Department of Dermatology,Xiangya Hospital,Central South University,Changsha 410008,China

National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology,Changsha 410008,China

Furong Laboratory,Changsha 410008,China

Hunan Key Laboratory of Skin Cancer and Psoriasis,Hunan Engineering Research Center of Skin Health and Disease,Xiangya Hospital,Central South University,Changsha 410008,China

National Clinical Research Center for Geriatric Disorders,Xiangya Hospital,Changsha 410008,Chi

Department of Oncology,Xiangya Hospital,Central South University,Changsha 410008,China

展开 >

National Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaNatural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan ProvinceNatural Science Fund for Outstanding Youths in Hunan ProvinceNational Key Research and Development Program

8210318382102803822728492022JJ407672021JJ409762023JJ200932022YFC2504700

2024

10.1186/s40779-023-00497-1

军事医学研究(英文)

军事医学研究(英文)

CSTPCD
ISSN：2095-7467
年,卷(期)：2024.11(4)